We have previously demonstrated that tranilast, which is one of anti-allergic drugs, acted HPMCs resulted in inhibition of tumor growth and fibrosis by suppressing Smad2/3 phosphorylation of the TGF-β/Smad pathway [41]. Here, TGFB1 is linked to neoplasm.